USPTO serial 88774013
REPERTOIRE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 23, 2021
- Examiner
- YOUNG, THOMAS PAUL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with REPERTOIRE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Cambridge, MA, US
REPERTOIRE IMMUNE MEDICINES, INC.
CAMBRIDGE, MA, US
REPERTOIRE IMMUNE MEDICINES, INC.
CAMBRIDGE, MA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CHRISTINA M. LICURSI
CHRISTINA M. LICURSI WOLF, GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | therapeutic products for medical purposes in the nature of biological preparations, biological tissue cultures and cell-based therapeutics in the nature of genetically modified cells used to modulate an immune response; pharmaceutical preparations used to modulate an immune response; pharmaceuticals and medical preparations for immunotherapy, cell therapy, immune cell therapy, and T-cell therapy for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system; pharmaceuticals and medical preparations for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system; pharmaceuticals and medical preparations in the nature of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, antibodies, cell therapeutics, cells, immune cells, and T-cells for use in the prevention and treatment of cancer, tumors, and diseases and disorders of the immune system | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cogen Immune Medicine, Inc.
- Other trademarks owned by REPERTOIRE IMMUNE MEDICINES, INC.
- Other trademarks owned by REPERTOIRE IMMUNE MEDICINES, INC.
- Other trademarks in Class 005
- Similar marks named REPERTOIRE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 23, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 7, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 7, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 7, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 23, 2021 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Feb 12, 2021 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 12, 2021 | AAUA | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | — |
| Feb 11, 2021 | ALIE | ASSIGNED TO LIE | — |
| Feb 11, 2021 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Feb 11, 2021 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Feb 11, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 11, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 11, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 11, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 11, 2021 | IUAA | USE AMENDMENT ACCEPTED | — |
| Feb 4, 2021 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Feb 4, 2021 | IUAF | USE AMENDMENT FILED | — |
| Feb 3, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 3, 2021 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| Feb 3, 2021 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 3, 2021 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 3, 2021 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Aug 3, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 3, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 3, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 15, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 21, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 15, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 8, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 30, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |